Literature DB >> 26001153

Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

Simona Coco1, Anna Truini, Irene Vanni, Carlo Genova, Camillo Rosano, Maria Giovanna Dal Bello, Angela Alama, Roberta Venè, Erika Rijavec, Giulia Barletta, Federica Biello, Francesco Boccardo, Francesco Grossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26001153     DOI： 10.1097/JTO.0000000000000538

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

1.  Case Report: Afatinib Sensitivity in Rare EGFR E746_L747delinsIP Mutated LUAD With Peritoneal Metastases.

Authors:  Lili Zhang; Lu Yang; Binxu Sun; Yixiao Deng; Jie Yang; Dongfang Wu; Fanming Kong
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

2.  The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma.

Authors:  Anna Truini; Jacqueline H Starrett; Tyler Stewart; Kumar Ashtekar; Zenta Walther; Anna Wurtz; David Lu; Jin H Park; Michelle DeVeaux; Xiaoling Song; Scott Gettinger; Daniel Zelterman; Mark A Lemmon; Sarah B Goldberg; Katerina Politi
Journal:  Clin Cancer Res       Date:  2019-06-10       Impact factor: 12.531

3.  Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity.

Authors:  Takahiro Yoshizawa; Ken Uchibori; Mitsugu Araki; Shigeyuki Matsumoto; Biao Ma; Ryo Kanada; Yosuke Seto; Tomoko Oh-Hara; Sumie Koike; Ryo Ariyasu; Satoru Kitazono; Hironori Ninomiya; Kengo Takeuchi; Noriko Yanagitani; Satoshi Takagi; Kazuma Kishi; Naoya Fujita; Yasushi Okuno; Makoto Nishio; Ryohei Katayama
Journal:  NPJ Precis Oncol       Date:  2021-04-16

4.  Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M.

Authors:  Yurong Wang; Ruipan Zheng; Peizhu Hu; Ziheng Zhang; Shujing Shen; Xingya Li
Journal:  BMC Cancer       Date:  2021-11-13       Impact factor: 4.430

5.  The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors.

Authors:  Guangjian Yang; Chengming Liu; Jiaqi Hu; Yang Sun; Peizeng Hu; Liu Liu; Haiyan Xu; Dazhou Li; Weihua Li; Yaning Yang; Nan Sun; Jie He; Yan Wang
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.